Charles Perry, PhD

Charles Perry, PhD has worked in the field of science since 2012. In 2012, they were an Undergraduate Research Assistant and Laboratory Technician at Syracuse University. From 2013 to 2018, they were a Graduate Student Researcher and Postdoctoral Researcher at Northeastern University and Vanderbilt Center for Neuroscience Drug Discovery, respectively. From 2020 to present, they have been a Research Scientist I and II at the Broad Institute of MIT and Harvard, where they are a project co-lead of an interdisciplinary team of scientists focused on cutting edge targets in the oncology space. Charles is currently a Scientist II at Arrakis Therapeutics.

Charles Perry, PhD received their Doctor of Philosophy (Ph.D.) in Medicinal and Pharmaceutical Chemistry from Northeastern University in 2018. Prior to that, they obtained a Bachelor's Degree in Biochemistry from Syracuse University in 2013.